No treatments are currently available to cure Parkinson’s disease. Better understanding the genetic foundation of this condition can help researchers find ways to slow or halt its progression.
Academic rigour, journalistic flair
Articles on Parkinson's research
Displaying all articles
This AI tool showed promise for early diagnosis. It also pointed to chemicals that may reduce or increase the risk of Parkinson’s.
A THC-like substance that occurs naturally in humans and other vertebrates helps maintain immunity, memory, nerve function and more – and research suggests a lack of it can harm health.
If governments want to tackle drug use, targeting those at most risk is a better strategy than mass campaigns.
The treatment is called ‘expiratory muscle strength training’; it is an exercise program targeting the muscles used when you swallow or cough.
Parkinson’s results from the deterioration of neurons in part of the brain called the basal ganglia.
Our study found lower levels of one type of immune cell – which may even be seen years before a person develops the disease.
Neurotrophic factors play an important role in protecting neurons – which is why researchers are investigating them as a treatment for Parkinson’s.
Parkinson’s disease may be diagnosed by looking for subtle changes in eye movements and thinning of retina layers.
Thomas Durcan’s lab is growing 3D mini-brains in the search for a cure for Parkinson’s disease. Over the next year he is giving all his lab’s protocols, methods and results away.
Alan Alda announced July 31, 2018 that he’s been living with Parkinson’s Disease. An expert on the disease explains new drugs and treatments.
There’s optimism that the identification of genes linked to Parkinson’s could lead to better treatments.
Top contributors
-
Associate Professor of Neuroscience, University of Oxford
-
NIHR academic clinical fellow and incoming PhD student, University of Oxford
-
Wellcome Trust Senior Research Fellow in Clinical Science, University of Dundee
-
Project Manager and Adjunct Associate Lecturer, University of Newcastle
-
Reader in Neurology and Neuroepidemiology, Queen Mary University of London
-
Assistant Professor, Neurodegenerative disorders, McGill University
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Ophthalmology, UCL
-
Research Fellow, Ophthalmology, UCL
-
Professor in Anatomy and Neuroscience, University College Cork
-
Professor and Head of Department of Anatomy & Neuroscience, University College Cork
-
Professor of Neurology, University of Florida
-
Senior Lecturer, Curtin University
-
Professor of Neurology, Radboud University
